Matches in Wikidata for { <http://www.wikidata.org/entity/Q92378993> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q92378993 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92378993 description "scientific article published on 31 December 2019" @default.
- Q92378993 description "wetenschappelijk artikel" @default.
- Q92378993 description "наукова стаття, опублікована 31 грудня 2019" @default.
- Q92378993 name "A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas" @default.
- Q92378993 name "A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas" @default.
- Q92378993 type Item @default.
- Q92378993 label "A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas" @default.
- Q92378993 label "A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas" @default.
- Q92378993 prefLabel "A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas" @default.
- Q92378993 prefLabel "A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas" @default.
- Q92378993 P1433 Q92378993-D0CD6481-381D-4BFA-8A86-F3B78CDF8E0E @default.
- Q92378993 P1476 Q92378993-41EAFE60-1F40-4548-91A5-9CECC3839F33 @default.
- Q92378993 P2093 Q92378993-028CB586-03A0-4948-BF5D-65BC59BF6373 @default.
- Q92378993 P2093 Q92378993-0DC3B56D-4879-4A35-9171-EFBA7BF02A1F @default.
- Q92378993 P2093 Q92378993-28F42570-388D-4B15-9482-23C0C6574F88 @default.
- Q92378993 P2093 Q92378993-495E2474-1D8A-4AC3-9302-9E1292D392A6 @default.
- Q92378993 P2093 Q92378993-73000B83-D0E6-4A6C-92AD-987E401640CB @default.
- Q92378993 P2093 Q92378993-9890C43B-C934-48A8-9F65-863FE6116B4E @default.
- Q92378993 P2093 Q92378993-99FE7C5E-3DE0-4CD8-B008-E1B439AC9164 @default.
- Q92378993 P2093 Q92378993-C89A95A2-D17F-4D91-B529-C9EEB6B33AD8 @default.
- Q92378993 P2093 Q92378993-ED57FD24-DA10-4CFC-9701-7F034C750128 @default.
- Q92378993 P2093 Q92378993-F758D076-2C4B-4CD8-962B-379EE0A34A2F @default.
- Q92378993 P2093 Q92378993-F8784A35-8A28-4011-848A-DCBB91AB7C77 @default.
- Q92378993 P304 Q92378993-A872B330-FDDA-4FF6-99FC-825DB546299B @default.
- Q92378993 P31 Q92378993-39E0ABF2-162B-4FB5-B6D0-00AC4EFFA70F @default.
- Q92378993 P356 Q92378993-7AEA21A2-BED9-4D25-AF2D-B5CBD92E9B94 @default.
- Q92378993 P478 Q92378993-2E3EB246-E3CF-400D-8F47-3F439EA27862 @default.
- Q92378993 P577 Q92378993-78245AD6-3762-4FB2-BFD2-CC819A5BC6E4 @default.
- Q92378993 P698 Q92378993-C2A24086-0F48-4490-9305-A0215600E817 @default.
- Q92378993 P356 J.EJCA.2019.10.021 @default.
- Q92378993 P698 31896519 @default.
- Q92378993 P1433 Q332260 @default.
- Q92378993 P1476 "A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas" @default.
- Q92378993 P2093 "Adrian Marino-Enriquez" @default.
- Q92378993 P2093 "Andrew J Wagner" @default.
- Q92378993 P2093 "Edwin Choy" @default.
- Q92378993 P2093 "George Demetri" @default.
- Q92378993 P2093 "Gregory M Cote" @default.
- Q92378993 P2093 "Jeffrey Morgan" @default.
- Q92378993 P2093 "Katherine Thornton" @default.
- Q92378993 P2093 "Michael J Nathenson" @default.
- Q92378993 P2093 "Priscilla Merriam" @default.
- Q92378993 P2093 "Suzanne George" @default.
- Q92378993 P2093 "Tianqi Chen" @default.
- Q92378993 P304 "21-32" @default.
- Q92378993 P31 Q13442814 @default.
- Q92378993 P356 "10.1016/J.EJCA.2019.10.021" @default.
- Q92378993 P478 "126" @default.
- Q92378993 P577 "2019-12-31T00:00:00Z" @default.
- Q92378993 P698 "31896519" @default.